See original release here March 22, 2017 [OTTAWA] – Canada’s biotech industry today welcomed the federal budget and its measures supporting the advancement of Canadian innovation in biotechnology centered sectors such as health/bio-sciences, clean technology and agri-food. Importantly the budget proposes support for the acceleration of innovation through the establishment of sector specific superclusters, including…

Working to improve diagnosis and treatment for patients with diabetic retinopathy Nearly 90 percent of people living with diabetes will eventually go blind. Diabetic retinopathy is caused by diseased vessels in the retina leaking blood components or hemorrhaging. The affects increasingly distort vision because of scarring of the retina and, in its most advanced stage, leads…

Originally featured in LINK Magazine Revolutionizing the way people are repositioned in wheelchairs in homes, hospitals and care facilities around the world. Nova Scotians working in the healthcare sector have the highest rate of workplace injury compared to any other industry, with musculoskeletal injuries to healthcare workers costing Nova Scotia taxpayers $100 million annually. These…

Women with dense breasts are at five times increased risk of developing breast cancer than women with fatty breasts because dense breast tissue obscures underlying cancers that grow in this tissue, creating a masking effect that can make the images difficult to read for radiologists. Densitas, located in Halifax, is working to eliminate the subjectivity…

Founded in 1983, Precision BioLogic (formerly Precision Biologicals) originally developed conventional diagnostic coagulation products that were sold in Atlantic Canada and some markets overseas. The company had minimal success, however, because its products had few distinct advantages over other products on the market. In 1991, with support from one of the company’s shareholders, Michael Scott,…

2015 © Copyright - Bionova